App-Quantinova.ai

High peripheral monocyte count is associated with increased risk of venous thromboembolism in patients with advanced pancreatic cancer

S. Dâmaso - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Primary Granulomatous Hypophysitis with Panhypopituitarism, presenting as Aseptic Meningitis in a 14-year-old boy

Eve Stern - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

hGH

Pectoral nerve and parasternal block combination in breast cancer surgery: subcutaneous mastectomy with reconstruction under regional anesthesia and sedation. A case study

F Marrone - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dexamethasone

Indicators that pocus is here to stay for anaesthesiologists too!

A Makris - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Regional anesthesia – the new gold standard in the intensive care unit?

C Chaves - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Ropivacaine

Comparative effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty

JF Reichel - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Tranexamic acid

PDPH in non-obstetric population. A problem or myth? A problem

Petros Tzimas - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Caffeine

Persistent headache in the parturient: PDPH or something more sinister?

Kassiani Theodoraki - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A RETROSPECTIVE ANALYSIS OF VENOUS THROMBOEMBOLISM INCIDENCE AMONGST PATIENTS WITH MEMBRANOUS NEPHROPATHY: A SINGLE CENTRE EXPERIENCE. IS ANTI-PLA2R AN ACCESSORY OR AN ACCOMPLICE?

V. JEYALAN - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

THROMBOEMBOLISM IN PRIMARY NEPHROTIC SYNDROME

T. McDonnell - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

VASCULAR ACCESS FAILURE IN A PATIENT WITH FACTOR V LEIDEN HOMOZYGOUS MUTATION

N. BASHIR - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Warfarin

AORTIC ARCH THROMBUS CAUSING BILATERAL RENAL INFARCTIONs WITH NORMAL RENAL FUNCTION IN SARS-COV2 INFECTED PATIENT: STATUS POST LAPAROTOMY AND END TO END ANASTAMOSIS

N. BASHIR - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Atorvastatin

CORRELATION OF NEUTROPHIL TO LYMPHOCYTE RATIO AND D-DIMER AS THROMBOSIS PREDICTOR ON REGULAR HAEMODIALYSIS PATIENT WITH COVID-19

I.G.N. Agung Tresna Erawan - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Incidence of venous thromboembolism in patients with advanced staged ovarian cancer undergoing neoadjuvant chemotherapy

Anousheh Shafa - Society of Gynecologic Oncology (SGO) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Clinical relevance of ovarian vein thrombosis and the risk of secondary venous thromboembolic events in women with gynecologic cancers

Michelle Greenman - Society of Gynecologic Oncology (SGO) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Using machine learning to predict venous thromboembolism in patients with uterine cancer

Vincent Wagner - Society of Gynecologic Oncology (SGO) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Impact of venous thromboembolism on timing and outcomes of interval debulking surgery among patients treated with neoadjuvant chemotherapy for advanced ovarian cancer

Julia Salinaro - Society of Gynecologic Oncology (SGO) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Incidence of venous thromboembolism (VTE) in ovarian cancer patients on low dose aspirin

Crystal Johnson - Society of Gynecologic Oncology (SGO) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

Unilateral Upper Extremity Thrombosis with Typical Chest Pain as the First Presentation of Metastatic Necrotic Thymoma

C. H. Vyas - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

rivaroxaban

Refractory Hypoxemic Respiratory Failure Secondary to Hepatopulmonary Syndrome in a Pediatric Patient

A. Wannes Daou - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Filters

7277 Abstracts